A Zanaflex, Sirdalud CEP of the European Pharmacopoeia monograph is often referred to as a Zanaflex, Sirdalud Certificate of Suitability (COS). The purpose of a Zanaflex, Sirdalud CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zanaflex, Sirdalud EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zanaflex, Sirdalud to their clients by showing that a Zanaflex, Sirdalud CEP has been issued for it. The manufacturer submits a Zanaflex, Sirdalud CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zanaflex, Sirdalud CEP holder for the record. Additionally, the data presented in the Zanaflex, Sirdalud CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zanaflex, Sirdalud DMF.
A Zanaflex, Sirdalud CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zanaflex, Sirdalud CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zanaflex, Sirdalud suppliers with CEP (COS) on PharmaCompass.